NPMc+ Cooperates With Flt3/Itd Mutations to Cause Acute Leukemia Recapitulating Human Disease

Experimental Hematology - Netherlands
doi 10.1016/j.exphem.2013.10.005
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

8-Chloro-Adenosine Activity in FLT3-ITD Acute Myeloid Leukemia

Journal of Cellular Physiology
Clinical BiochemistryCell BiologyPhysiology
2019English

FLT3 Mutations in Canine Acute Lymphocytic Leukemia

BMC Cancer
Cancer ResearchOncologyGenetics
2011English

DNA Damage on the DOCK in FLT3-ITD-driven Acute Myeloid Leukemia

Haematologica
Hematology
2019English

Dnmt3a Deletion Cooperates With the Flt3/Itd Mutation to Drive Leukemogenesis in a Murine Model

Oncotarget
Oncology
2016English

Targeting BTK for the Treatment of FLT3-ITD Mutated Acute Myeloid Leukemia

Scientific Reports
Multidisciplinary
2015English

DOCK2: A Novel FLT3/ITD Leukemia Drug Target

Oncotarget
Oncology
2017English

Clinical Outcome of Patients With Acute Promyelocytic Leukemia and FLT3 Mutations

American Journal of Hematology
Hematology
2010English

FLT3 Mutations in Childhood Acute Lymphoblastic Leukemia at First Relapse

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2005English

The Clinical Significance of FLT3 ITD Mutation on the Prognosis of Adult Acute Promyelocytic Leukemia

Hematology
Hematology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy